Combined analysis of mRNA expression of ERCC1, BAG-1, BRCA1, RRM1 and TUBB3 to predict prognosis in patients with non-small cell lung cancer who received adjuvant chemotherapy

The overexpression of ERCC-1 is involved in the resistance of lung cancer cells to cetuximab combined with DDP

(2010) Jing-Jing Li et al.   CANCER BIOLOGY & THERAPY

Gene silencing of BAG-1 modulates apoptotic genes and sensitizes lung cancer cell lines to cisplatin-induced apoptosis

(2010) Hongyu Liu et al.   CANCER BIOLOGY & THERAPY

Expression of Class III Beta-Tubulin Correlates with Unfavorable Survival Outcome in Patients with Resected Non-small Cell Lung Cancer

(2010) Youngil Koh et al.   Journal of Thoracic Oncology

XPG mRNA Expression Levels Modulate Prognosis in Resected Non–Small-Cell Lung Cancer in Conjunction with BRCA1 and ERCC1 Expression

(2009) Roberta Bartolucci et al.   Clinical Lung Cancer

Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy

(2009) Jian Li et al.   LUNG CANCER

Positive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancer

(2009) Xin Wang et al.   MEDICAL ONCOLOGY

Customized Treatment in Non-Small-Cell Lung Cancer Based on EGFR Mutations and BRCA1 mRNA Expression

(2009) Rafael Rosell et al.   PLoS One

Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy

(2008) Shuji Ota et al.   LUNG CANCER

Expression of ERCC1 and class III β-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel

(2008) Koichi Azuma et al.   LUNG CANCER

ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer

(2007) Kyung-Hun Lee et al.   LUNG CANCER